Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Conditions: Mycosis Fungoides - Sezary Syndrome
Location: Nashville, Tennessee
- Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
Conditions: Schizophrenia - Schizoaffective Disorder - Bipolar Disorder - Major Depression
Location: Nashville, Tennessee
- Bradykinin Receptor Antagonism During Cardiopulmonary Bypass- Specific Aim 3
Conditions: Coronary Arteriosclerosis
Location: Nashville, Tennessee
- Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
Conditions: Alzheimer's Disease
Location: Nashville, Tennessee
- High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone
Conditions: Schizophrenia - Schizoaffective Disorder
Location: Nashville, Tennessee
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Cookeville, Tennessee
- The RAS, Fibrinolysis and Cardiopulmonary Bypass
Conditions: Coronary Artery Disease - Angiotensin Converting Enzyme - Angiotensin Receptor Blockers - Cardiopulmonary Bypass - Fibrinolysis - Inflammation
Location: Nashville, Tennessee
- Letrozole in Treating Postmenopausal Women With Stage I or Stage II Breast Cancer That Can Be Removed by Surgery
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Restoration of Leg Length, Offset, and Center of Rotation in Total Hip Replacement
Conditions: Arthritis
Location: Nashville, Tennessee
- Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery
Conditions: Acute Kidney Injury - Post-Operative Delirium - Icu Delirium - Acute Renal Failure - Delirium
Location: Nashville, Tennessee
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roc
Conditions: Hepatitis C, Chronic
Location: Nashville, Tennessee
- Is Levocetirizine Less Sedating Than Cetirizine?
Conditions: Allergic Rhinitis
Location: Nashville, Tennessee
- A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer
Conditions: Triple Negative Breast Cancer
Location: Nashville, Tennessee
- Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors
Conditions: Arthralgia - Breast Cancer
Location: Nashville, Tennessee
- Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Conditions: Pregnancy - Aneuploidy - Down Syndrome - Edwards Syndrome
Location: Nashville, Tennessee
- Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Conditions: Pregnancy - Aneuploidy - Down Syndrome - Edwards Syndrome
Location: Nashville, Tennessee
- Bone Graft Materials Observational Registry
Conditions: Degenerative Disc Disease - Herniated Disc - Spinal Stenosis - Spondylolithesis - Spinal Deformity - Cervical Myelopathy - Failed Back Surgery Syndrome - Spinal Cord Neoplasms
Location: Nashville, Tennessee
- IMGN901 in Combination With Lenalidomide and Dexamethasone
Conditions: Multiple Myeloma
Location: Nashville, Tennessee
- A Study of RO5185426 in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)
Conditions: Malignant Melanoma
Location: Nashville, Tennessee
- Comparison Study of Two Different Surgical Clips During Laparoscopic Urologic Surgery
Conditions: Prostatectomy - Nephrectomy - Laparoscopy - Robotics
Location: Nashville, Tennessee
- A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
Conditions: Non Small Cell Lung Cancer
Location: Nashville, Tennessee
- Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study
Conditions: Glaucoma - Macular Pucker - Macula Hole - Vitreomacular Traction - Vitreous Opacities or Hemorrhage
Location: Nashville, Tennessee
- A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded
Conditions: Major Depressive Disorder
Location: Nashville, Tennessee
- Long-Term Data Collection From Participants in Adult AIDS Clinical Trials
Conditions: HIV Infections
Location: Nashville, Tennessee
- Consent for Use of Stored Patient Specimens for Future Testing
Conditions: HIV Infections
Location: Nashville, Tennessee
- Insulin Resistance Intervention After Stroke Trial
Conditions: Stroke - Myocardial Infarction - Diabetes
Location: Nashville, Tennessee
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Nashville, Tennessee
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: Nashville, Tennessee
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Nashville, Tennessee
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Nashville, Tennessee
- Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
Conditions: Cancer
Location: Nashville, Tennessee
- Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergo
Conditions: Breast Cancer - Lymphedema - Perioperative/Postoperative Complications
Location: Cookeville, Tennessee
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Nashville, Tennessee
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Brentwood, Tennessee
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Goodlettsville, Tennessee
- Evaluation of PROCHYMAL[tm] Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease
Conditions: Crohn's Disease
Location: Germantown, Tennessee
- Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Conditions: Ovarian Cancer - Renal Cancer - Non-small Cell Lung Cancer - Small Cell Lung Cancer - Solid Tumors - Multiple Myeloma
Location: Nashville, Tennessee
- A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
Conditions: Parkinson's Disease Psychosis
Location: Brentwood, Tennessee
- VA NEPHRON-D: Diabetes iN Nephropathy Study
Conditions: Kidney Disease - Nephropathy - Type 2 Diabetes
Location: Nashville, Tennessee
- Study of Nutrition in Acute Pancreatitis
Conditions: Pancreatitis
Location: Nashville, Tennessee
- A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
Conditions: Breast Cancer, - Advanced Solid Tumors, - Cowden Syndrome
Location: Nashville, Tennessee
- Sorafenib Long Term Extension Program (STEP)
Conditions: Neoplasms
Location: Nashville, Tennessee
- Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
Location: Nashville, Tennessee
- TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
Conditions: Pulmonary Tuberculosis
Location: Nashville, Tennessee
- Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
Location: Nashville, Tennessee
- Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Conditions: Myelogenous Leukemia, Chronic
Location: Nashville, Tennessee
- A Multi-site Randomized Controlled Trial Comparing Regional and General Anesthesia for Effects on Neurodevelopmental Outcome and Apnea in Infants
Conditions: Inguinal Hernia
Location: Nashville, Tennessee
- A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CON
Conditions: B-cell Chronic Lymphocytic Leukemia
Location: Nashville, Tennessee
- AngelMed for Early Recognition and Treatment of STEMI
Conditions: Acute Myocardial Infarction (AMI) - Coronary Occlusion - Acute Coronary Syndrome
Location: Nashville, Tennessee
- Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Murfreesboro, Tennessee
- Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
Conditions: Type 2 Diabetes Mellitus
Location: Nashville, Tennessee
- Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Conditions: Solid Tumors - Neoplasms, Breast - Cancer
Location: Nashville, Tennessee
- Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer
Conditions: Tumor - Ovarian Cancer
Location: Nashville, Tennessee
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Conditions: Asthma
Location: Nashville, Tennessee
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
Location: Gallatin, Tennessee
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
Location: Hermitage, Tennessee
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
Location: Lebanon, Tennessee
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
Location: Murfreesboro, Tennessee
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
Location: Nashville, Tennessee
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
Location: Nashville, Tennessee
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
Location: Nashville, Tennessee
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
Location: Smyrna, Tennessee
- Chloroquine for Reducing Immune Activation in HIV- Infected Individuals
Conditions: HIV Infections
Location: Nashville, Tennessee
- An Open-Label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine+Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Ca
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Genetic Determinants of Response to Beta Blockade
Conditions: Healthy
Location: Nashville, Tennessee
- A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma, Solid Cancers
Location: Nashville, Tennessee
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Gallatin, Tennessee
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Lebanon, Tennessee
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Murfreesboro, Tennessee
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Nashville, Tennessee
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Nashville, Tennessee
- Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Ca
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Conditions: Epilepsy With Simple or Complex Partial Onset Seizures
Location: Nashville, Tennessee
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Cookeville, Tennessee
- Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis
Conditions: Suspected Eosinophilic Esophagitis
Location: Nashville, Tennessee
- Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
Conditions: Liver Cancer
Location: Nashville, Tennessee
- Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Nashville, Tennessee
- Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Conditions: Lung Cancer
Location: Nashville, Tennessee
- Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Conditions: Cancer
Location: Murfreesboro, Tennessee
- Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Conditions: Cancer
Location: Nashville, Tennessee
- Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Conditions: Cancer
Location: Nashville, Tennessee
- Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Conditions: Cancer
Location: Nashville, Tennessee
- Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Conditions: Cancer
Location: Nashville, Tennessee
- Eslicarbazepine Acetate Monotherapy Long Term Study
Conditions: Epilepsy
Location: Nashville, Tennessee
- PAVES: Pegfilgrastim Anti-VEGF Evaluation Study
Conditions: Cancer - Colon Cancer - Colorectal Cancer - Fever - Locally Advanced - Metastatic Colorectal Cancer - Neutropenia - Rectal Cancer
Location: Nashville, Tennessee
- Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease
Conditions: Contrast Induced Kidney Injury.
Location: Nashville, Tennessee
- Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lympho
Conditions: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
Location: Nashville, Tennessee
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Gallatin, Tennessee
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Hermitage, Tennessee
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Lebanon, Tennessee
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Murfreesboro, Tennessee
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Nashville, Tennessee
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Nashville, Tennessee
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Nashville, Tennessee
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Smyrna, Tennessee
- Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors
Conditions: Neoplasms
Location: Nashville, Tennessee
- Study of Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Advanced Non-Small Cell Lung Cancer
Location: Nashville, Tennessee
- A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Conditions: ErbB2 Overexpressing - Solid Tumors - Metastatic Breast Cancer - Neoplasms, Breast
Location: Nashville, Tennessee
- A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0973 in Combination With GDC-0941 When Administered in Patients With Locally A
Conditions: Solid Cancers
Location: Nashville, Tennessee
- A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Conditions: Advanced Solid Tumors With FGFR1 Amplication, - Advanced Solid Tumors With FGFR2 Amplication, - Advanced Solid Tumors With FGFR3 Mutation
Location: Nashville, Tennessee
- Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL)
Conditions: Refractory Cutaneous T-cell Lymphoma
Location: Nashville, Tennessee
- Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
Conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer - Metastatic Breast Cancer
Location: Nashville, Tennessee
- Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
Conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer - Metastatic Breast Cancer
Location: Nashville, Tennessee
- A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors
Location: Nashville, Tennessee
- Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymp
Conditions: Lymphoma, Large-Cell, Diffuse
Location: Nashville, Tennessee
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Nashville, Tennessee
- Treximet for Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction
Conditions: Post-Traumatic Headache
Location: Nashville, Tennessee
- Dose Escalation Study of INK128 in Subjects With Advanced Cancer
Conditions: Advanced Solid Malignancies
Location: Nashville, Tennessee
- Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212
Conditions: Cancer
Location: Nashville, Tennessee
- Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to
Conditions: Lymphoma, Non-Hodgkin - Lymphoma, Follicular
Location: Nashville, Tennessee
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Nashville, Tennessee
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: Nashville, Tennessee
- Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-
Conditions: Squamous Cell Lung Cancer
Location: Nashville, Tennessee
- A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Conditions: Head and Neck Neoplasms
Location: Nashville, Tennessee
- Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodg
Conditions: Indolent Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma
Location: Nashville, Tennessee
- An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Conditions: Chronic Lymphocytic Leukemia - Lymphoma, Non-Hodgkin - Acute Myeloid Leukemia - Multiple Myeloma
Location: Nashville, Tennessee
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Conditions: Diarrhea Predominant Irritable Bowel Syndrome
Location: Hermitage, Tennessee
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Conditions: Diarrhea Predominant Irritable Bowel Syndrome
Location: Nashville, Tennessee
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Personalized Prevention of Colorectal Cancer Trial
Conditions: Colorectal Cancer
Location: Nashville, Tennessee
- A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Solid Cancers
Location: Nashville, Tennessee
- Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
Conditions: Advanced Non-clear Cell Renal Cell Carcinoma
Location: Nashville, Tennessee
- Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
Conditions: Advanced Non-clear Cell Renal Cell Carcinoma
Location: Nashville, Tennessee
- A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Conditions: Colon Cancer - Rectal Cancer
Location: Gallatin, Tennessee
- A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Conditions: Colon Cancer - Rectal Cancer
Location: Hermitage, Tennessee
- A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Conditions: Colon Cancer - Rectal Cancer
Location: Lebanon, Tennessee
- A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Conditions: Colon Cancer - Rectal Cancer
Location: Murfreesboro, Tennessee
- A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Conditions: Colon Cancer - Rectal Cancer
Location: Nashville, Tennessee
- A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Conditions: Colon Cancer - Rectal Cancer
Location: Nashville, Tennessee
- A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Conditions: Colon Cancer - Rectal Cancer
Location: Nashville, Tennessee
- A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Conditions: Colon Cancer - Rectal Cancer
Location: Smyrna, Tennessee
- A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic B
Conditions: Breast Cancer
Location: Nashville, Tennessee
- A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic B
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
Conditions: Advanced Heart Failure
Location: Nashville, Tennessee
- Proximal Femur Locking Compression Plates Versus Trochanteric Nails
Conditions: Reverse Oblique Intertrochanteric Fractures - Reverse Oblique Subtrochanteric Fractures
Location: Nashville, Tennessee
- Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed
Conditions: Metastatic Breast Cancer - Trastuzumab - BKM120 - HER2+
Location: Nashville, Tennessee
- Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
Conditions: Brain Injuries
Location: Nashville, Tennessee
- A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
Conditions: Hepatorenal Syndrome Type 1
Location: Nashville, Tennessee
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Nashville, Tennessee
- Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)
Conditions: Acute Myeloid Leukemia (AML)
Location: Nashville, Tennessee
- Safety Study of MGAH22 in HER2-positive Carcinomas
Conditions: Breast Cancer - Gastric Cancer - Bladder Cancer - Ovarian Cancer - Non-small Cell Lung Cancer
Location: Nashville, Tennessee
- A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer
Conditions: Lymphoma - Non-Hodgkin's Lymphoma - Hodgkin Disease - Multiple Myeloma - Leukemia - Lymphocytic - Chronic
Location: Nashville, Tennessee
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Gallatin, Tennessee
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Hermitage, Tennessee
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Lebanon, Tennessee
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Murfreesboro, Tennessee
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Nashville, Tennessee
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Nashville, Tennessee
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Nashville, Tennessee
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Nashville, Tennessee
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Smyrna, Tennessee
- Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
Conditions: Steatohepatitis
Location: Nashville, Tennessee
- Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors
Conditions: Neoplasm - Cancer - Tumors
Location: Nashville, Tennessee
- Childhood Obesity Prevention Program for Hispanics
Conditions: Childhood Obesity
Location: Nashville, Tennessee
- Notch Inhibitor in Advanced Cancer
Conditions: Advanced Cancer
Location: Nashville, Tennessee
- A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin With or Without IMC-1121B in Patients Previously Untreate
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Nashville, Tennessee
- A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Conditions: Psoriasis
Location: Nashville, Tennessee
- Trial of the PresView Implant for the Improvement of Near Vision in Patients With Presbyopia
Conditions: Presbyopia
Location: Nashville, Tennessee
- An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepat
Conditions: Hepatitis C, Chronic
Location: Nashville, Tennessee
- Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors
Conditions: Solid Tumor
Location: Nashville, Tennessee
- A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
Conditions: Parkinson's Disease Psychosis
Location: Brentwood, Tennessee
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
Location: Nashville, Tennessee
- An Extension Protocol for Subjects Who Were Previously Enrolled in Other ARQ 197 Protocols
Conditions: Advanced Solid Tumors
Location: Nashville, Tennessee
- Evaluation of the WATCHMAN LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy
Conditions: Atrial Fibrillation - Stroke
Location: Nashville, Tennessee
- A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To S
Conditions: Psoriasis
Location: Nashville, Tennessee
- Study Evaluating the Safety and Efficacy of Onartuzumab (Metmab) And/Or Bevacizumab in Combination With Paclitaxel in Patients With Metastatic, Triple
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Conditions: Leukemia - Acute Myeloid Leukemia - Acute Nonlymphocytic Leukemia
Location: Nashville, Tennessee
- Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrex
Conditions: Cancer
Location: Nashville, Tennessee
- Study Comparing Orteronel Plus Prednisone in Patients With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Nashville, Tennessee
- Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Nashville, Tennessee
- A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus - Connective Tissue Disease - Autoimmune Disease
Location: Nashville, Tennessee
- A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
Conditions: Adenocarcinoma of the Lung
Location: Nashville, Tennessee
- A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene
Conditions: Advanced Solid Tumors - With an Alteration of the PIK3CA Gene
Location: Nashville, Tennessee
- A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or Lymphoma
Conditions: Solid Cancers
Location: Nashville, Tennessee
- A Phase 1 Study in Advanced Cancer
Conditions: Advanced Cancer
Location: Nashville, Tennessee
- A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors
Conditions: Metastatic or Unresectable Solid Tumor Malignancy
Location: Nashville, Tennessee
- CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Conditions: Chronic Myelogenous Leukemia in Chronic Phase
Location: Nashville, Tennessee
- A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors
Conditions: Cancer
Location: Nashville, Tennessee
- Study of IMC-18F1 or Ramucirumab DP in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients
Conditions: Breast Cancer
Location: Nashville, Tennessee
- A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
Conditions: Advanced Solid Tumor - Lymphomas
Location: Nashville, Tennessee
- A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Conditions: Solid Tumors
Location: Nashville, Tennessee
- Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia (AML)
Location: Nashville, Tennessee
- A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In
Conditions: Smoking Cessation
Location: Nashville, Tennessee
- A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Conditions: Stomach Cancer - Esophageal Cancer
Location: Nashville, Tennessee
- PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
Location: Nashville, Tennessee
- Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subject
Conditions: Cancer
Location: Nashville, Tennessee
- A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
Conditions: Advanced Solid Tumors
Location: Nashville, Tennessee
- Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Meta
Conditions: Breast Cancer
Location: Nashville, Tennessee
- LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Conditions: Irritable Bowel Syndrome
Location: Murfreesboro, Tennessee
- A Study of the Effect of Food on the Pharmacokinetics of Single Dose RO5185426 And the Safety And Efficacy of Continuous Administration in Patients Wi
Conditions: Malignant Melanoma
Location: Nashville, Tennessee
- A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme
Location: Nashville, Tennessee
- E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Patients With Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
Location: Nashville, Tennessee
- Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Conditions: Fibromyalgia
Location: Nashville, Tennessee
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Cookeville, Tennessee
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults
Conditions: Invasive Meningococcal Disease
Location: Lebanon, Tennessee
- A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Conditions: Crohn's Disease
Location: Nashville, Tennessee
- A Trial of Levodopa in Angelman Syndrome
Conditions: Angelman Syndrome
Location: Nashville, Tennessee
- A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile
Conditions: Fragile X Syndrome
Location: Nashville, Tennessee
- Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
Conditions: Indolent Non-Hodgkin Lymphoma - Follicular Lymphoma - Small Lymphocytic Lymphoma - Lymphoplasmacytoid Lymphoma - Marginal Zone Lymphoma
Location: Nashville, Tennessee
- Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
Conditions: Colitis, Ulcerative
Location: Nashville, Tennessee
- Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carbopla
Conditions: Lung Cancer - Non Small Cell
Location: Cookeville, Tennessee
- Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Conditions: Cervical Dystonia - Blepharospasm
Location: Nashville, Tennessee
- A Study of Obinutuzumab (RO5072759) in Combination With CHOP Chemotherapy Versus MabThera/Rituxan (Rituximab) With CHOP in Patients With CD20-Positive
Conditions: Lymphoma, B-Cell
Location: Nashville, Tennessee
- Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Conditions: Autism Spectrum Disorders
Location: Nashville, Tennessee
- BKM120 as Second-line Therapy for Advanced Endometrial Cancer
Conditions: Advanced Endometrial Cancer
Location: Nashville, Tennessee
- Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Conditions: Advanced Solid Malignant Tumors - Advanced Ovarian Cancer
Location: Nashville, Tennessee
- A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
Location: Nashville, Tennessee
- Safety Study of X-82 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors
Location: Nashville, Tennessee
- Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
Location: Nashville, Tennessee
- Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hosp
Conditions: Heart Failure
Location: Nashville, Tennessee
- INcrease Of VAgal TonE in CHF
Conditions: Left Ventricular Dysfunction - Heart Failure
Location: Nashville, Tennessee
- A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Locally Advanced or Metastatic Breast or Colorectal Cancer
Location: Nashville, Tennessee
- Diabetic Peripheral Neuropathic Pain (DPNP)
Conditions: Diabetic Peripheral Neuropathic Pain
Location: Nashville, Tennessee
- A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers
Conditions: Metastatic Cancer
Location: Nashville, Tennessee
- GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Conditions: Crohn's Disease
Location: Nashville, Tennessee
- Open-Label Extension Study of GSK1605786A
Conditions: Crohn's Disease
Location: Nashville, Tennessee
- DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury
Conditions: Brain Injuries - Craniocerebral Trauma - Trauma, Nervous System - Traumatic Brain Injury
Location: Nashville, Tennessee
- Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
Conditions: Central Neuropathic Pain - Multiple Sclerosis
Location: Nashville, Tennessee
- A Fixed-Dose Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Children Wi
Conditions: Fragile X Syndrome
Location: Nashville, Tennessee
- Comparative Effectiveness Study for Bipolar Disorder
Conditions: Bipolar Disorder
Location: Nashville, Tennessee
- Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy
Conditions: Tonsillectomy
Location: Hendersonville, Tennessee
- E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
Conditions: Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
Location: Nashville, Tennessee
- Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Conditions: Pain
Location: Hendersonville, Tennessee
- Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma
Location: Nashville, Tennessee
- Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer
Conditions: Ovarian Cancer
Location: Nashville, Tennessee
- A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repea
Conditions: Drug Interactions - BRAF - Cancer
Location: Nashville, Tennessee
- A Phase 1 Study of LY2787106 in Cancer and Anemia
Conditions: Anemia
Location: Nashville, Tennessee
- Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors
Conditions: Solid Tumor Malignancy
Location: Nashville, Tennessee
- Long-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X Syndrome
Conditions: Fragile X Syndrome
Location: Nashville, Tennessee
- Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme
Location: Nashville, Tennessee
- Dose Escalation Study of INK128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
Conditions: Breast Cancer
Location: Nashville, Tennessee
- Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer
Conditions: Cancer
Location: Nashville, Tennessee
- Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Conditions: Multiple Myeloma - Non-Hodgkin's Lymphoma - Glioblastoma Multiforme - Head and Neck Squamous Cell Cancer - Triple Negative Breast Cancer - Hormone Receptor-Positive Breast Cancer - Castration-Resistant Prostate Cancer - Ewing's Family of Sarcomas
Location: Nashville, Tennessee
- A Rollover Study for Subjects Who Participated in Other Romidepsin Protocols
Conditions: Lymphoma - Cancer
Location: Nashville, Tennessee
- BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
Conditions: Renal Cell Carcinoma
Location: Nashville, Tennessee
- Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
Conditions: Muscle Wasting - Non-Small Cell Lung Cancer
Location: Nashville, Tennessee
- Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
Conditions: Fragile X Syndrome
Location: Nashville, Tennessee
- Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Solid Tumors
Location: Nashville, Tennessee
- Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)
Conditions: Leukemia
Location: Nashville, Tennessee
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: Nashville, Tennessee
- A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory So
Conditions: Solid Tumour
Location: Nashville, Tennessee
- Safety and PK Study of RRx-001 in Cancer Subjects
Conditions: Malignant Solid Tumor - Lymphomas
Location: Nashville, Tennessee
|